My musings on the future of CTIX SELL COMPANY Pros:  Dr

New Post Public Reply Private Reply Replies (1) Message Board
petemantx TheProgressive #8086

My musings on the future of CTIX

SELL COMPANY

Pros:  Dr Menon getting on in years and may want to finalize everything ASAP and then continue with Kard Scientific to satisfy his lab work passions.  Everyone cashes out immediately.  Lots of resources get thrown by the purchasing company to complete work on his current pipeline of possible medicines.  Dr Menon realizes the fruits of his lifelong labors and earns the worldwide fame he deserves.  Should Dr Menon die prior to sale, who takes over his position as Chief Scientific Officer to pursue further work down the road?  Sale makes everything neat and tidy.

Cons:  Would selling to a big pharma cause a major reluctance from all the other big pharmas to put money into research for combo drugs relating to Kevetrin and Prurisol?  Would they work with another big pharma to bring such products to market?  Would they want their efforts to be financially profitable to their competitor?  In the end, would this route lessen the good K,P, and the other pipeline drugs might be able to do because nobody but the buyer of CTIX would put money into developing them into as many fine combo cocktails as possible?  Dr M's products are seen as competition by all of big pharmas except one company.

PARTNERING/LICENSING PRODUCTS WITH BIG PHARMAS

Pros:  By staying as a going concern, CTIX becomes a feedstock for major products that ALL big pharmas can use to partner with their own unique products and thus big pharma looks at CTIX as a provider of revenue streams as opposed to being a competitor since they not be marketing any products themselves.  Any of them can hop on the CTIX product express and attain new revenue streams.  This would allow for the most avenues for wide dissemination of K/P in possible combos down the line.

Cons:  Means Dr M/LE have to stay in the game and run this going concern and they may be at a point in their lives where this is no longer the lifestyle they want.  No immediate end of game pot of gold for investors but should start a continuously growing stream of revenues coming into CTIX to be distributed as dividends or other such means.  IMO this would be the avenue for the largest total amount of return to CTIX investors.  Trade off is do you want a LARGE amount of money now or an EVEN LARGER amount of money spread out over what could be a considerable time period?

This thinking could be inane, but it sure is fun to consider such possibilities where each possible outcome is extremely positive to the CTIX investor.

Last thought for consideration re: stock price in Aug.    Will major investors, both individuals and financial institutions, wait to follow the SP before investing or wait for trials results to begin investing?  I think by Aug we have a pretty good handle on both K/P working and even if the stock price is not going up like a rocket there should be a couple of BIG investors that can read the writing on the wall and beat the herd to the stock and thus start driving the price up.  That is what I believe is going to take the SP up by the end of Aug.  Nice to see how close this comes to reality knowing if I am wrong it will correct itself within a matter of months to the upside.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Inside Kristallnacht: An XR Journey for a New World

Updated Category News Views 0

Bridging the Past with Powerful Tech: A Journey to Kristallnacht Let's cut to the chase: if there's a time in history that we all need to sear into our collective consciousness, it's Kristallnacht. Forget the mere notion of reading it from a textbook; now you can dive headfirst into the harrowing events of November 9, 1938, thanks to the cutting-edge initiative inside...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 99

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 124

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Wuliangye Aims for Global Branding Boost at Panda Event

Updated Category News Views 109

Wuliangye Takes Center Stage at Global Event Everyone's chasing that global branding magic, but here's Wuliangye strutting its stuff at the Global Panda Partners Conference. Held in Sichuan Province from November 2 to 4, this is not just another show; it's a bold move from the Chinese baijiu maker to push the 'harmony and coexistence' mantra on the world stage. Not just...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 417

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Korean 'Glocal' Districts Entice U.S. Tourists with Local Flavor

Updated Category News Views 0

Gwangju's Dongmyeong-dong is like the neighborhood artists and hipsters flock to in New York—except it’s got a Korean twist. Nestled in the Jeonnam region, this place is hot on American tourists' radar for its spicy mix of local culture, unique eats, and shops that scream individuality. It's becoming a magnet for folks who want to get a taste of Korean life but with a...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 180

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Tencent Cloud's Edge Platform Shines in New Gartner Report

Updated Category News Views 24

The Breakthrough in Edge Computing Everyone's talking about cloud this and cloud that, but Tencent Cloud is taking things a notch further with its EdgeOne platform. It's not just about storing your files in the sky; it's about having the fastest, most secure delivery possible. Gartner's latest report puts these guys right at the top in their Magic Quadrant for Edge...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 664

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
AI Shopping Surge: WeFetch.ai's Bold Rebrand Move

Updated Category News Views 0

Shifting Gears: GreenCore Solutions Becomes WeFetch.ai Here's a shift you don't see every day. GreenCore Solutions has morphed into WeFetch.ai, aiming to sail the ever-growing AI shopping seas. This isn't just a new nameplate; it's a declaration of intent to dive headfirst into the market dynamics driven by artificial intelligence. It's bold and, frankly, pretty timely....

Continue Reading

Top 5 Most Recently Viewed Articles

IDEMIA and Hyundai: The Future of Automotive Connectivity

Updated Category News Views 209

The Game-Changer Partnership This takes me back to the days when the auto industry was grappling with technology shifts—like when they finally started putting airbags in every car. IDEMIA Secure Transactions (that’s IST for the initiated) is teaming up with Hyundai Motor Group (HMG), one of the big players in the automaker space. They're rolling out what they call a...

Continue Reading
Exciting Opportunities: Northern 3 VCT PLC Subscription Offer

Updated Category News Views 133

Exciting Subscription Offer for Investors Northern 3 VCT PLC is thrilled to announce an enticing opportunity for potential investors as it opens its offers for new ordinary shares in the 2025/26 tax year. This offer comes in conjunction with the Northern Venture Trust PLC and Northern 2 VCT PLC, collectively known as the Northern VCTs. The announcement has created a buzz...

Continue Reading
Join the Movement: Protect Your Rights as an AMLX Investor

Updated Category News Views 105

Understanding Shareholder Rights As a shareholder of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), it’s imperative to be aware of your rights and the actions you can take to safeguard your interests. With the ever-evolving landscape of corporate governance, understanding the power of your voice becomes crucial. Immediate action is often necessary, as there may be limited...

Continue Reading
Canadian Government Announces Important Housing Initiative

Updated Category News Views 113

Government Initiatives on Housing The Government of Canada has taken a pivotal step in addressing housing challenges with an important announcement regarding housing initiatives. In a dedicated approach to tackle housing-related issues, key figures from the government have come together to discuss these steps. This initiative demonstrates the government's commitment to...

Continue Reading
Innovative AI Ecosystem for Enhanced Cancer Care Announced

Updated Category News Views 241

Transforming Cancer Care with AI Innovations Lunit and Volpara have introduced a groundbreaking Ecosystem at RSNA 2024, focusing on advanced AI capabilities to enhance cancer detection and improve patient outcomes. At this significant event, Lunit (KRX:328130.KQ), known for its AI-powered solutions in cancer diagnostics, along with Volpara Health, a leader in breast...

Continue Reading